Marco Capasso

Consigliere Generale presso WCG CLINICAL, INC.

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Marco Capasso

Società	Posizione	Inizio	Fine
WCG CLINICAL, INC.	Consigliere Generale	-	-

Società	Posizione	Inizio	Fine
ImClone Systems LLC ImClone Systems LLC BiotechnologyHealth Technology Part of Eli Lilly & Co., ImClone Systems LLC is a company that develops and manufactures biologics for the treatment of cancer. The company is based in Bridgewater, NJ.	Direttore/Membro del Consiglio	-	-
	Corporate Officer/Principal	-	-
PAREXEL International LLC PAREXEL International LLC Miscellaneous Commercial ServicesCommercial Services Part of PAREXEL International Corp., PAREXEL International LLC is a company that operates as a Contract Research Organization (CRO) and provides clinical development services. The company is based in Newton, MA.	Consigliere Generale	-	-

The Trustees of Columbia University in The City of New York

Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

General Counsel	2
Director/Board Member	1
Corporate Officer/Principal	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
PAREXEL International LLC PAREXEL International LLC Miscellaneous Commercial ServicesCommercial Services Part of PAREXEL International Corp., PAREXEL International LLC is a company that operates as a Contract Research Organization (CRO) and provides clinical development services. The company is based in Newton, MA.	Commercial Services
ImClone Systems LLC ImClone Systems LLC BiotechnologyHealth Technology Part of Eli Lilly & Co., ImClone Systems LLC is a company that develops and manufactures biologics for the treatment of cancer. The company is based in Bridgewater, NJ.	Health Technology
WCG Clinical, Inc. WCG Clinical, Inc. BiotechnologyHealth Technology WCG Clinical, Inc. provides clinical trial solutions, which focus on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance. It transformational solutions enable biopharmaceutical companies, contract research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human protection. The company was founded in 2012 and is headquartered in Princeton, NJ.	Health Technology